Davide Leone & Partners Investment CO Ltd. Insmed Inc Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $531,619 - $792,039	-21,995 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $709,998 - $974,378	21,995 New	21,995 $749,000

Others Institutions Holding INSM

# of Institutions

466

Shares Held

180M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.19 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$993 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$876 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$731 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$454 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.43B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account